Key Takeaways
- Q4 FY25 earnings release scheduled for March 2, 2026
- Analysts project a $0.02 per share loss, significantly improved from last year’s $0.47 loss
- Estimated revenue of $390K represents substantial growth from prior year’s $62K
- Shares declined 8.4% on February 27, now trading beneath key technical indicators
- Options market anticipates approximately 14.05% volatility following the announcement
Quantum Computing Inc. prepares to unveil its fourth-quarter fiscal 2025 financial results this coming Monday, March 2, 2026. The company’s shares experienced turbulence leading up to the announcement, with an 8.4% decline on February 27 that pushed the closing price to $8.278.
Daily trading activity registered approximately 3.37 million shares — a dramatic 78% reduction compared to the typical 15 million share average. Such subdued volume during a selloff often suggests uncertain market sentiment, though it doesn’t provide the complete picture.
The current price point places shares underneath both the 50-day moving average of $10.35 and the 200-day moving average of $13.70. Despite recent weakness, QUBT maintains a year-over-year gain exceeding 39%, propelled primarily by enthusiasm surrounding its photonic computing innovations.
Financial analysts anticipate a quarterly loss of $0.02 per share for the final quarter of 2025. This projection represents meaningful progress compared to the $0.47 per share deficit recorded during the corresponding period last year.
Revenue projections stand at $390K, a significant jump from the $62K generated in Q4 2024. Although absolute figures remain modest, the trajectory continues to capture analyst attention.
Luminar Acquisition Takes Center Stage
Among the most significant developments entering this earnings discussion is the company’s $110 million all-cash purchase of Luminar Semiconductor Inc., formerly a Luminar Technologies subsidiary. This strategic acquisition aims to provide QUBT enhanced autonomy over its technology infrastructure while accelerating the path toward consistent revenue generation.
Market participants will be closely monitoring management commentary regarding semiconductor manufacturing schedules, customer fulfillment progress, and preliminary revenue contributions stemming from this transaction.
Price Targets Adjusted Downward
Wall Street opinion remains divided. Lake Street analyst Max Michaelis maintained his Buy recommendation while reducing his price objective from $24 to $16 — still suggesting approximately 77% potential appreciation from present levels.
Ascendiant Capital Markets similarly adjusted its forecast downward, moving from $40 to $25 while preserving a Buy stance. Taking a more measured approach, Wedbush launched coverage with a Neutral rating paired with a $12 target, and Cantor Fitzgerald reaffirmed its Neutral position at $15.
Rosenblatt Securities initiated coverage this past January with a Buy recommendation and $22 price target. The aggregate consensus lands at Moderate Buy, comprising one Strong Buy, two Buys, two Holds, and one Sell among monitored analysts.
The mean price target across all coverage stands at $18.00, implying roughly 99% upside potential from the February 27 trading level.
QUBT exhibits a beta coefficient of 3.44, indicating substantial volatility relative to broader market movements. The company commands a market capitalization near $1.83 billion, with a negative P/E ratio of -13.40 consistent with its current pre-profit phase.
Insider ownership accounts for 19.3% of outstanding shares. COO Milan Begliarbekov divested 2,860 shares on January 7 at $11.85 per share, decreasing his holdings by approximately 10.55%. Institutional investment remains minimal at just 4.26%.
The options market currently prices in potential movement of roughly 14.05% in either direction once earnings results are released.
Fourth-quarter fiscal 2025 results are scheduled for release prior to Monday’s market opening on March 2, 2026.


